Calcium stabilizes fibrillin-1 against proteolytic degradation

Dieter P. Reinhardt, Robert N. Ono, Lynn Sakai

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

The calcium-binding epidermal growth factor (cbEGF)-like domain is a structural motif that is present in many matrix proteins throughout the animal kingdom from invertebrates to mammals. This module has been demonstrated to bind calcium in the micromolar range. However, little is known about the functional consequences of calcium binding to proteins that contain this structural element. We used fibrillin-1, an extracellular matrix protein consisting of ~60% cbEGF-like motifs, as a model system to study stabilizing effects of calcium in protease degradation assays. Authentic human fibrillin-1 and recombinant human fibrillin-1 subdomains, spanning the whole molecule, showed significantly slower proteolytic degradation in the presence of CaCl2 than in the presence of EDTA, demonstrating that calcium stabilizes the structure of fibrillin-1 and protects the molecule against proteolytic degradation. Information about cleavage sites protected by calcium was obtained with a new recombinant subdomain, rF17 (Asp952- Val1527), comprising the longest stretch of cbEGF-like motifs in the center of the fibrillin-1 molecule. The most sensitive sites for trypsin and endoproteinase Glu-C were observed in cbEGF-like motifs 11 (Met1034 and Asn1046), 12 (Ser1103), and 17 (Thr1318). Since most of the currently known mutations in fibrillin-1 are found within cbEGF-like motifs and are predicted to disrupt calcium binding, we suggest that these mutations render fibrillin-1 more susceptible to proteolytic cleavage, and this might be one of the reasons why these mutations result in Marfan's syndrome.

Original languageEnglish (US)
Pages (from-to)1231-1236
Number of pages6
JournalJournal of Biological Chemistry
Volume272
Issue number2
DOIs
StatePublished - Jan 25 1997

Fingerprint

Calcium
Degradation
Epidermal Growth Factor
Mutation
Molecules
Fibrillin-1
Marfan Syndrome
Calcium-Binding Proteins
Extracellular Matrix Proteins
Mammals
Invertebrates
Edetic Acid
Trypsin
Peptide Hydrolases
Assays
Animals
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Calcium stabilizes fibrillin-1 against proteolytic degradation. / Reinhardt, Dieter P.; Ono, Robert N.; Sakai, Lynn.

In: Journal of Biological Chemistry, Vol. 272, No. 2, 25.01.1997, p. 1231-1236.

Research output: Contribution to journalArticle

Reinhardt, Dieter P. ; Ono, Robert N. ; Sakai, Lynn. / Calcium stabilizes fibrillin-1 against proteolytic degradation. In: Journal of Biological Chemistry. 1997 ; Vol. 272, No. 2. pp. 1231-1236.
@article{23cbf2f6d1fe4ea78d50a6acc0e3b1ac,
title = "Calcium stabilizes fibrillin-1 against proteolytic degradation",
abstract = "The calcium-binding epidermal growth factor (cbEGF)-like domain is a structural motif that is present in many matrix proteins throughout the animal kingdom from invertebrates to mammals. This module has been demonstrated to bind calcium in the micromolar range. However, little is known about the functional consequences of calcium binding to proteins that contain this structural element. We used fibrillin-1, an extracellular matrix protein consisting of ~60{\%} cbEGF-like motifs, as a model system to study stabilizing effects of calcium in protease degradation assays. Authentic human fibrillin-1 and recombinant human fibrillin-1 subdomains, spanning the whole molecule, showed significantly slower proteolytic degradation in the presence of CaCl2 than in the presence of EDTA, demonstrating that calcium stabilizes the structure of fibrillin-1 and protects the molecule against proteolytic degradation. Information about cleavage sites protected by calcium was obtained with a new recombinant subdomain, rF17 (Asp952- Val1527), comprising the longest stretch of cbEGF-like motifs in the center of the fibrillin-1 molecule. The most sensitive sites for trypsin and endoproteinase Glu-C were observed in cbEGF-like motifs 11 (Met1034 and Asn1046), 12 (Ser1103), and 17 (Thr1318). Since most of the currently known mutations in fibrillin-1 are found within cbEGF-like motifs and are predicted to disrupt calcium binding, we suggest that these mutations render fibrillin-1 more susceptible to proteolytic cleavage, and this might be one of the reasons why these mutations result in Marfan's syndrome.",
author = "Reinhardt, {Dieter P.} and Ono, {Robert N.} and Lynn Sakai",
year = "1997",
month = "1",
day = "25",
doi = "10.1074/jbc.272.2.1231",
language = "English (US)",
volume = "272",
pages = "1231--1236",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "2",

}

TY - JOUR

T1 - Calcium stabilizes fibrillin-1 against proteolytic degradation

AU - Reinhardt, Dieter P.

AU - Ono, Robert N.

AU - Sakai, Lynn

PY - 1997/1/25

Y1 - 1997/1/25

N2 - The calcium-binding epidermal growth factor (cbEGF)-like domain is a structural motif that is present in many matrix proteins throughout the animal kingdom from invertebrates to mammals. This module has been demonstrated to bind calcium in the micromolar range. However, little is known about the functional consequences of calcium binding to proteins that contain this structural element. We used fibrillin-1, an extracellular matrix protein consisting of ~60% cbEGF-like motifs, as a model system to study stabilizing effects of calcium in protease degradation assays. Authentic human fibrillin-1 and recombinant human fibrillin-1 subdomains, spanning the whole molecule, showed significantly slower proteolytic degradation in the presence of CaCl2 than in the presence of EDTA, demonstrating that calcium stabilizes the structure of fibrillin-1 and protects the molecule against proteolytic degradation. Information about cleavage sites protected by calcium was obtained with a new recombinant subdomain, rF17 (Asp952- Val1527), comprising the longest stretch of cbEGF-like motifs in the center of the fibrillin-1 molecule. The most sensitive sites for trypsin and endoproteinase Glu-C were observed in cbEGF-like motifs 11 (Met1034 and Asn1046), 12 (Ser1103), and 17 (Thr1318). Since most of the currently known mutations in fibrillin-1 are found within cbEGF-like motifs and are predicted to disrupt calcium binding, we suggest that these mutations render fibrillin-1 more susceptible to proteolytic cleavage, and this might be one of the reasons why these mutations result in Marfan's syndrome.

AB - The calcium-binding epidermal growth factor (cbEGF)-like domain is a structural motif that is present in many matrix proteins throughout the animal kingdom from invertebrates to mammals. This module has been demonstrated to bind calcium in the micromolar range. However, little is known about the functional consequences of calcium binding to proteins that contain this structural element. We used fibrillin-1, an extracellular matrix protein consisting of ~60% cbEGF-like motifs, as a model system to study stabilizing effects of calcium in protease degradation assays. Authentic human fibrillin-1 and recombinant human fibrillin-1 subdomains, spanning the whole molecule, showed significantly slower proteolytic degradation in the presence of CaCl2 than in the presence of EDTA, demonstrating that calcium stabilizes the structure of fibrillin-1 and protects the molecule against proteolytic degradation. Information about cleavage sites protected by calcium was obtained with a new recombinant subdomain, rF17 (Asp952- Val1527), comprising the longest stretch of cbEGF-like motifs in the center of the fibrillin-1 molecule. The most sensitive sites for trypsin and endoproteinase Glu-C were observed in cbEGF-like motifs 11 (Met1034 and Asn1046), 12 (Ser1103), and 17 (Thr1318). Since most of the currently known mutations in fibrillin-1 are found within cbEGF-like motifs and are predicted to disrupt calcium binding, we suggest that these mutations render fibrillin-1 more susceptible to proteolytic cleavage, and this might be one of the reasons why these mutations result in Marfan's syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0031030185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031030185&partnerID=8YFLogxK

U2 - 10.1074/jbc.272.2.1231

DO - 10.1074/jbc.272.2.1231

M3 - Article

C2 - 8995426

AN - SCOPUS:0031030185

VL - 272

SP - 1231

EP - 1236

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 2

ER -